ER decision-support tool aims to boost addiction care
NCT ID NCT07602218
First seen May 22, 2026 · Last updated May 22, 2026
Summary
This study tests a computer tool that helps emergency room doctors follow best practices for starting buprenorphine in patients with opioid use disorder. About 300 adults with moderate to severe opioid use disorder will take part. The goal is to see if the tool increases the number of patients who get a referral to an addiction counselor and start medication in the ER.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Yale New Haven Hospital
New Haven, Connecticut, 06510, United States
-
Yale New Haven Hospital- St. Raphael
New Haven, Connecticut, 06510, United States
-
Yale New Haven Shoreline Medical Center
Guilford, Connecticut, 06437, United States
Conditions
Explore the condition pages connected to this study.